Mark McCormack

7PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 17, 2022
A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam.

Ciarán Campbell, Mark McCormack, Sonn Patel

|May 21, 2021
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy.

Stefan Wolking, Claudia Moreau, Mark McCormack

|Feb 12, 2021
Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.

Bianca Berghuis, Janic Hulst, Anja Sonsma

|Mar 07, 2020
Testing association of rare genetic variants with resistance to three common antiseizure medications.

Stefan Wolking, Claudia Moreau, Anne T Nies

|Dec 11, 2019
Genomic and clinical predictors of lacosamide response in refractory epilepsies.

Sinéad B Heavin, Mark McCormack, Stefan Wolking

Pageof 2